These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 7973768

  • 21. Concurrent paclitaxel, carboplatin, and radiation therapy for locally advanced non-small cell lung cancer.
    Choy H, Akerley W, DeVore RF.
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):36-43. PubMed ID: 10190782
    [Abstract] [Full Text] [Related]

  • 22. Combined modality therapy of lung cancer.
    Livingston RB.
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2638-47. PubMed ID: 10068267
    [Abstract] [Full Text] [Related]

  • 23. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
    Rusu P, Ciuleanu TE, Cernea D, Pelau D, Gaal V, Cebotaru C, Guttman T, Todor N, Ghilezan N.
    J BUON; 2007 Dec; 12(1):33-9. PubMed ID: 17436399
    [Abstract] [Full Text] [Related]

  • 24. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y, Ueoka H, Kiura K, Kamei H, Tabata M, Sakae K, Hiraki Y, Kawahara S, Eguchi K, Hiraki S, Harada M.
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [Abstract] [Full Text] [Related]

  • 25. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [Abstract] [Full Text] [Related]

  • 26. One-hour paclitaxel in the treatment of non-small cell lung cancer.
    Hainsworth JD, Greco FA.
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):98-101. PubMed ID: 9007133
    [Abstract] [Full Text] [Related]

  • 27. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R, Zatloukal P, Jassem J, Schwarzenberger P, Orlov SV, Gottfried M, Pereira JR, Temperley G, Negro-Vilar R, Rahal S, Zhang JK, Negro-Vilar A, Dziewanowska ZE.
    J Clin Oncol; 2008 Apr 10; 26(11):1886-92. PubMed ID: 18398154
    [Abstract] [Full Text] [Related]

  • 28. New treatment agents for advanced small cell and non-small cell lung cancer.
    Bunn PA, Kelly K.
    Semin Oncol; 1995 Jun 10; 22(3 Suppl 6):53-63. PubMed ID: 7597434
    [Abstract] [Full Text] [Related]

  • 29. Management (chemotherapy/best supportive care) of advanced-stage non-small cell lung cancer.
    Carney DN.
    Semin Oncol; 1995 Aug 10; 22(4 Suppl 9):58-62. PubMed ID: 7644930
    [Abstract] [Full Text] [Related]

  • 30. The role of docetaxel (Taxotere) as a single agent or in combination before local treatment of non-small cell lung cancer.
    Harper P.
    Semin Oncol; 1997 Aug 10; 24(4 Suppl 14):S14-30-S14-32. PubMed ID: 9335522
    [Abstract] [Full Text] [Related]

  • 31. [Recent progress in chemotherapy for advanced lung cancer].
    Negoro S, Fukuoka M.
    Gan To Kagaku Ryoho; 1995 Mar 10; 22(4):451-60. PubMed ID: 7887637
    [Abstract] [Full Text] [Related]

  • 32. Combination chemotherapy with vinorelbine (Navelbine) and mitoxantrone for metastatic breast cancer: a review.
    Vogel CL.
    Semin Oncol; 1995 Apr 10; 22(2 Suppl 5):61-5. PubMed ID: 7740335
    [Abstract] [Full Text] [Related]

  • 33. Oral vinorelbine (Navelbine) in the treatment of advanced non-small cell lung cancer: a preliminary report.
    Vokes EE, Rosenberg R, Jahanzeb M, Craig J, Gralla R, Belani C, Jones S, Bigley J, Hohneker J.
    Semin Oncol; 1994 Oct 10; 21(5 Suppl 10):35-8; discussion 38-41. PubMed ID: 7973767
    [Abstract] [Full Text] [Related]

  • 34. Chemoradiation for locally advanced, unresectable NSCLC. New standard of care, emerging strategies.
    Gordon GS, Vokes EE.
    Oncology (Williston Park); 1999 Aug 10; 13(8):1075-88; discussion 1088, 1091-4. PubMed ID: 10499243
    [Abstract] [Full Text] [Related]

  • 35. New approaches in the adjuvant and neoadjuvant therapy of non-small cell lung cancer, including docetaxel (Taxotere) combinations.
    Rosell R.
    Semin Oncol; 1999 Jun 10; 26(3 Suppl 11):32-7. PubMed ID: 10458209
    [Abstract] [Full Text] [Related]

  • 36. [The status of chemotherapy in non-small-cell bronchial carcinoma].
    Drings P, Manegold C.
    Strahlenther Onkol; 1994 Sep 10; 170(9):495-506. PubMed ID: 7940122
    [Abstract] [Full Text] [Related]

  • 37. Treatment of non-small-cell lung cancer in North America: the emerging role of irinotecan.
    Langer CJ.
    Oncology (Williston Park); 2001 Jan 10; 15(1 Suppl 1):19-24. PubMed ID: 11221017
    [Abstract] [Full Text] [Related]

  • 38. Chemotherapy in non-small cell lung cancer: results of recent trials.
    Gralla RJ, Kris MG.
    Semin Oncol; 1988 Jun 10; 15(3 Suppl 4):2-5. PubMed ID: 2839904
    [Abstract] [Full Text] [Related]

  • 39. Neoadjuvant chemotherapy for non-small cell lung cancer.
    Pinder-Schenck M, Bepler G.
    Minerva Chir; 2009 Dec 10; 64(6):611-28. PubMed ID: 20029358
    [Abstract] [Full Text] [Related]

  • 40. Future directions for vinorelbine (Navelbine).
    Hortobagyi GN.
    Semin Oncol; 1995 Apr 10; 22(2 Suppl 5):80-6; discussion 86-7. PubMed ID: 7740338
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.